A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques

被引:35
作者
Sun, LM
Huang, HY
Huang, EY
Wang, CJ
Ko, SF
Lin, H
Song, JC
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung Hsien, Taiwan
[4] Chang Gung Mem Hosp, Dept Gynecol, Kaohsiung Hsien, Taiwan
关键词
cervical carcinoma; intracavitary brachytherapy; bladder distension; computed tomography; bladder and rectal wall doses;
D O I
10.1016/j.radonc.2005.03.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Intracavitary brachytherapy (ICBT) is as important as external beam radiotherapy (EBRT) for the radical radiotherapy of uterine cervical cancer. The degree of urinary bladder distension during ICBT may affect the dose distribution in the bladder and rectum, to which an overdose may increase the chance of developing treatment-related complications. The purpose of this prospective study was to assess and quantify the impact of bladder distension on dosimetry in ICBT in patients with cervical cancer. Patients and methods: We recruited 20 patients with cervical cancer during a 12-month period. Inclusion criteria included pathological diagnosis of cervical cancer with IA to IIIB stages, and intact uterus. Patients were evaluated for brachytherapy after EBRT, and eligible individuals (cervical as could be identified clearly) were invited enter to this protocol to receive ICBT. In the first brachytherapy, bladder preparation (evacuation and distension by a Foley catheter) and CT scan were performed soon after the insertion of CT-compatible applicators. Then the bladder wall doses [median dose, maximum dose and dose-volume histograms (DVH)] were calculated via the PLATO computer planning system (Nucletron PLATO-RTS version 2.0). The individual data regarding doses and DVH were collected and compared. Bladder distension may shift the applicator position, and posterior displacement of the applicator system may increase the dose to the rectal wall, so this effect was also evaluated. Results: All the continuous variables of these 20 patients followed a normal distribution. By paired t-test and multiple linear regression analysis, we found that bladder distension statistically significantly decreased the median bladder wall dose with an average reduction of 48% of the dose of an empty bladder (P<0.001), and the maximum dose did not change; on the other hand, the bladder distension did not have any adverse effects on the rectal wait doses. Conclusions: Using CT-assisted three-dimensional techniques to assess the bladder and rectal wall doses is feasible. Bladder distension reduces the median dose in the bladder wait, which may reduce treatment-related complications. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 26 条
[1]  
[Anonymous], RADIUM DOSAGE MANCHE
[2]  
[Anonymous], 2002, ANAL LONGITUDINAL DA
[3]   Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer [J].
Buchali, A ;
Koswig, S ;
Dinges, S ;
Rosenthal, P ;
Salk, J ;
Lackner, G ;
Böhmer, D ;
Schlenger, L ;
Budach, V .
RADIOTHERAPY AND ONCOLOGY, 1999, 52 (01) :29-34
[4]   Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer [J].
Chen, HC ;
Leung, SW ;
Wang, CJ ;
Sun, LM ;
Fang, FM ;
Huang, EY ;
Wang, SJ ;
Yang, CW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03) :541-544
[5]   The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy [J].
Chen, SW ;
Liang, JA ;
Yang, SN ;
Liu, RT ;
Lin, FJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :955-961
[6]  
*DEP HLTH, 2001, TAIW PUBL HLTH ANN R
[7]   Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects [J].
Fellner, C ;
Pötter, R ;
Knocke, TH ;
Wambersie, A .
RADIOTHERAPY AND ONCOLOGY, 2001, 58 (01) :53-62
[8]   Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma [J].
Gellrich, J ;
Hakenberg, OW ;
Oehlschläger, S ;
Wirth, MR .
ONKOLOGIE, 2003, 26 (04) :334-340
[9]   High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix - A randomized trial [J].
Hareyama, M ;
Sakata, K ;
Oouchi, A ;
Nagakura, H ;
Shido, M ;
Someya, M ;
Koito, K .
CANCER, 2002, 94 (01) :117-124
[10]   Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations [J].
Hellebust, TP ;
Dale, E ;
Skjonsberg, A ;
Olsen, DR .
RADIOTHERAPY AND ONCOLOGY, 2001, 60 (03) :273-280